Foot infections in patients with diabetes

American Family Physician

Volumn 56, Issue 1, 1997, Pages 195-202

  Caputo, Gregory M ^a   Joshi, Nirmal ^a   Weitekamp, Michael R ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; INFECTION; OSTEOMYELITIS; PATHOGENESIS; REVIEW; SENSORY NEUROPATHY; TREATMENT PLANNING;

DIABETIC FOOT; DIABETIC NEUROPATHIES; DIAGNOSIS, DIFFERENTIAL; FOOT; HUMANS; ISCHEMIA;

EID: 0030786996     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Bridges RM Jr, Deitch EA. Diabetic foot infections. Pathophysiology and treatment. Surg Clin North Am 1994;74:537-55.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
3. Boulton AJ. The pathway to ulceration: aetiopathogenesis. In: Boulton AJ, Connor H, Cavanagh PR, eds. The foot in diabetes. 2d ed. Chichester: Wiley, 1994:37-48.
4. Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabetic Med 1992;9:320-9.
5. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992;15:1386-9.
6. Birke JA, Sims DS. Plantar sensory threshold in the ulcerative foot. Lepr Rev 1986;57:261-7.
7. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990;13:1057-61.
8. Pomposelli FB Jr, Jepsen SJ, Gibbons GW, Campbell DR, Freeman DV, Miller A, et al. Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg 1990;11:745-52.
9. Beach KW, Brunzell JD, Strandness DE Jr. Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy. Arteriosclerosis 1982;2:275-80.
10. LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984;311:1615-9.
11. Jap AJ, Tooke JE. Is microvascular disease important in the diabetic foot? In: Boulton AJ, Connor H, Cavanagh PR, eds. The foot in diabetes. 2d ed. Chichester: Wiley, 1994:49-56.
12. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974;23:9-15.
13. Gibbons GW. Diabetic foot sepsis. Semin Vasc Surg 1992;5:244-8.
14. Gibbons GW, Eliopoulos GM. Infection of the diabetic foot. In: Kozak GP, Hoar CS Jr, Rowbotham JL, Wheelock FC Jr, Gibbons GW, Campbell D, eds. Management of diabetic foot problems. Joslin Clinic and New England Deaconess Hospital. Philadelphia: Saunders, 1984:97-102.
15. Grayson ML, Gibbons GW, Habershaw GM, Freeman DV, Pomposelli FB, Rosenblum BI, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-93 [Published erratum appears in Clin Infect Dis 1994;19:820].
16. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA 1991;266:1246-51.
17. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989; 149:2262-6.
18. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3.
19. Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, et al. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995;273:712-20.
20. Rosenblum BI, Pomposelli FB Jr., Giurini JM, Gibbons GW, Freeman DV, Chrzan JS, et al. Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes. A 5-year experience. Diabetes Care 1994;17:983-7.
21. Caputo GM, Ulbrecht JS, Cavanagh PR. The total contact cast: a method for treating neuropathic diabetic ulcers. Am Fam Physician 1997;55:605-16.
22. Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am 1990;4:409-32.
23. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990;150:790-7.
24. Tan JS, File TM Jr. Diagnosis and treatment of diabetic foot infections. Compr Ther 1988;14:57-62.
25. Boulton AJ. The diabetic foot. Med Clin North Am 1988;72:1513-30.
26. Wheat LJ, Allen SD, Henry M, Kernek CB, Siders JA, Kuebler T, et al. Diabetic foot infections. Bacteriologie analysis. Arch Intern Med 1986;146:1935-40.
27. Sapico FL, Witte JL, Canawati HN, Montgomerie JZ, Bessman AN. The infected foot of the diabetic patient Quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984;6(Suppl 1):S171-6.
28. Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding DN. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989;86(6 Pt 2):801-8.
29. Scher KS, Steele FJ. The septic foot in patients with diabetes. Surgery 1988;104:661-6.
30. Hughes CE, Johnson CC, Bamberger DM, Reinhardt JF, Peterson LR, Mulligan ME, et al. Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clin Ther 1987;10(Suppl A):36-49.
31. Sapico FL, Bessman AN, Canawati HN. Bacteremia in diabetic patients with infected lower extremities. Diabetes Care 1982;5:101-4.
32. Lefrock JL, Blais F, Schell RF, et al. Cefoxitin in the treatment of diabetic infections with lower extremity infections. Infect Surg 1983;2:361-74.
33. Kerins DM. Ampicillin/sulbactam - a combination of an old and a new agent in the treatment of infection. Am J Med Sci 1991;301:406-11.
34. Tan JS, File TM, Salstrom SJ. Timentin versus moxalactam in the treatment of skin and soft tissue infections. Am J Med 1985;79(Suppl 5B):130-3.
35. Piperacillin/tazobactam. Med Lett Drugs Ther 1994;36(914):7-9 [Published erratum appears in Med Lett Drugs Ther 1994;36(921):40].
36. Gentry LO. Antibiotic therapy for osteomyelitis. Infect Dis Clin North Am 1990;4:485-99.
37. Gilbert DN, Tice AD, Marsh PK, Craven PC, Preheim LC. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli. Am J Med 1987;82(Suppl 4A):254-8.
38. Greenberg RN, Kennedy DJ, Reilly PM, Luppen KL, Weinandt WJ, Bollinger MR, et al. Treatment of bone, joint and soft-tissue infections with oral ciprofloxacin. Antimicrob Agents Chemother 1987; 31:151-5.
39. Hessen MT, Ingerman MJ, Kauffman DH, Weiner P, Santoro J, Korzeniowski OM, et al. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Am J Med 1987;82(Suppl 4A): 262-5.
40. Hoogkamp-Korstanje JA, van Bottenburg HA, van Bruggen J, Davidson JS, Detmar SJ, de Graaf W, et al. Treatment of chronic osteomyelitis with ciprofloxacin. J Antimicrob Chemother 1989;23:427-32.
41. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors and the role of antimicrobial and surgical therapy. Am J Med 1987;83:653-60.